Rees Catherine J, Mouadeb Debbie A, Belafsky Peter C
The Center for Voice and Swallowing, University of California at Davis Medical Center, Department of Otolaryngology-Head and Neck Surgery, Sacramento, CA 95817, USA.
Otolaryngol Head Neck Surg. 2008 Jun;138(6):743-6. doi: 10.1016/j.otohns.2008.02.023.
To review the clinical results of the thyrohyoid approach for in-office vocal fold augmentation with calcium hydroxyapatite.
Retrospective chart review.
The charts of all persons who underwent in-office thyrohyoid vocal fold augmentation between June 1, 2005 and June 1, 2007 were reviewed. Information with respect to patient demographics, indications, complications, and clinical outcome was abstracted.
Fifty-one thyrohyoid vocal fold augmentations were performed in 33 patients (26 men; mean age, 66 years). Six (13%) procedures were aborted as a result of an inability to achieve an appropriate injection angle. Two (6%) self-limited complications included a vasovagal episode and a small ulcer near the petiole of the epiglottis. Pre- and postprocedure data were available for 62.5%. The mean 10-item Voice Handicap Index improved from 27.9 (+/-8.40) preprocedure to 13.5 (+/-10.52) postprocedure (P < 0.001).
In-office vocal fold augmentation with the use of the thyrohyoid approach demonstrates excellent clinical results. It has become our technique of choice for vocal fold medialization with the patient under local anesthesia in the office setting. Complications are rare.
回顾采用甲状舌骨入路在门诊用羟基磷灰石进行声带填充的临床效果。
回顾性病历分析。
回顾2005年6月1日至2007年6月1日期间所有在门诊接受甲状舌骨入路声带填充的患者病历。提取有关患者人口统计学、适应证、并发症和临床结果的信息。
33例患者（26名男性；平均年龄66岁）接受了51次甲状舌骨入路声带填充。6例（13%）手术因无法获得合适的注射角度而中止。2例（6%）自限性并发症包括1次血管迷走神经发作和会厌柄附近一个小溃疡。术前和术后数据可得率为62.5%。10项嗓音障碍指数平均分从术前的27.9（±8.40）改善至术后的13.5（±10.52）（P<0.001）。
采用甲状舌骨入路在门诊进行声带填充显示出优异的临床效果。它已成为我们在门诊局部麻醉下使声带内移的首选技术。并发症罕见。
